Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Oncogenic herpesvirus HHV-8 promotes androgen-independent prostate cancer growth.

Mygatt JG, Singhal A, Sukumar G, Dalgard CL, Kaleeba JA.

Cancer Res. 2013 Sep 15;73(18):5695-708. doi: 10.1158/0008-5472.CAN-12-4196. Epub 2013 Sep 4.

2.

Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.

Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G.

Endocr Relat Cancer. 2014 May 8;21(3):473-86. doi: 10.1530/ERC-13-0514. Print 2014 Jun.

PMID:
24812058
3.

Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer.

Bohrer LR, Chen S, Hallstrom TC, Huang H.

Endocrinology. 2010 Nov;151(11):5136-45. doi: 10.1210/en.2010-0436. Epub 2010 Sep 29.

4.

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.

Schweizer L, Rizzo CA, Spires TE, Platero JS, Wu Q, Lin TA, Gottardis MM, Attar RM.

BMC Cell Biol. 2008 Jan 24;9:4. doi: 10.1186/1471-2121-9-4.

5.

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

Jin RJ, Lho Y, Connelly L, Wang Y, Yu X, Saint Jean L, Case TC, Ellwood-Yen K, Sawyers CL, Bhowmick NA, Blackwell TS, Yull FE, Matusik RJ.

Cancer Res. 2008 Aug 15;68(16):6762-9. doi: 10.1158/0008-5472.CAN-08-0107.

6.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
7.

Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens.

Granchi S, Brocchi S, Bonaccorsi L, Baldi E, Vinci MC, Forti G, Serio M, Maggi M.

Prostate. 2001 Dec 1;49(4):267-77.

PMID:
11746273
8.

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.

Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW.

Prostate. 2007 Apr 1;67(5):521-35.

PMID:
17252539
9.

Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.

Zaia A, Fraizer GC, Piantanelli L, Saunders GF.

Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

PMID:
11299720
10.

Molecular regulation of androgen action in prostate cancer.

Dehm SM, Tindall DJ.

J Cell Biochem. 2006 Oct 1;99(2):333-44. Review.

PMID:
16518832
11.

Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.

Whitworth H, Bhadel S, Ivey M, Conaway M, Spencer A, Hernan R, Holemon H, Gioeli D.

PLoS One. 2012;7(6):e38950. doi: 10.1371/journal.pone.0038950. Epub 2012 Jun 27.

12.

Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.

Li L, Xie H, Liang L, Gao Y, Zhang D, Fang L, Lee SO, Luo J, Chen X, Wang X, Chang LS, Yeh S, Wang Y, He D, Chang C.

Carcinogenesis. 2013 Feb;34(2):257-67. doi: 10.1093/carcin/bgs337. Epub 2012 Oct 26.

14.

Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling.

Mink SR, Hodge A, Agus DB, Jain A, Gross ME.

Prostate. 2010 Aug;70(11):1201-10. doi: 10.1002/pros.21155.

PMID:
20564426
15.

NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.

Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.

Cancer Res. 2004 Aug 1;64(15):5489-95.

16.

Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G.

Cancer Res. 2006 May 15;66(10):5012-20.

17.
18.

Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells.

Sinha R, Pinto JT, Facompre N, Kilheffer J, Baatz JE, El-Bayoumy K.

Nutr Cancer. 2008;60(2):267-75. doi: 10.1080/01635580701630479.

PMID:
18444160
19.

Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.

Schmidt A, Meissner RS, Gentile MA, Chisamore MJ, Opas EE, Scafonas A, Cusick TE, Gambone C, Pennypacker B, Hodor P, Perkins JJ, Bai C, Ferraro D, Bettoun DJ, Wilkinson HA, Alves SE, Flores O, Ray WJ.

J Steroid Biochem Mol Biol. 2014 Sep;143:29-39. doi: 10.1016/j.jsbmb.2014.02.005. Epub 2014 Feb 22.

PMID:
24565564
20.

Androgen receptor signaling in androgen-refractory prostate cancer.

Grossmann ME, Huang H, Tindall DJ.

J Natl Cancer Inst. 2001 Nov 21;93(22):1687-97. Review.

PMID:
11717329

Supplemental Content

Support Center